Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune...

newstart_2024's profile picture

Camus

452,593 subscribers

103,022 görüntüleme • 10 ay önce •via X (Twitter)

Sağlık & İyilikBilim & TeknolojiEğitim
LIVE

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

Of all the casualties in the war on cancer, the most critical have been the most ignored: your NK and T cells. As Dr. Patrick Soon-Shiong explains, while oncology has long treated the anemia and neutropenia caused by chemotherapy, it has overlooked the destruction of the very immune cells that fight cancer. For 35 years, there was no treatment for this catastrophic side effect. That era is over. Dr. Soon-Shiong announces ANKTIVA, the first FDA-approved therapy proven to activate NK cells, T cells, and memory T cells. The result? Documented complete responses in bladder cancer patients, free of disease for over nine years. This breakthrough shatters a long-standing medical blind spot. Whether from chemo, radiation, or a severe viral infection, the body's primary defense is often wiped out. ANKTIVA represents a paradigm shift—from solely attacking disease to actively re-arming the patient's own immune system. The future of medicine is not just fighting the enemy, but empowering the army within.
3:35

Of all the casualties in the war on cancer, the most critical have been the most ignored: your NK and T cells. As Dr. Patrick Soon-Shiong explains, while oncology has long treated the anemia and neutropenia caused by chemotherapy, it has overlooked the destruction of the very immune cells that fight cancer. For 35 years, there was no treatment for this catastrophic side effect. That era is over. Dr. Soon-Shiong announces ANKTIVA, the first FDA-approved therapy proven to activate NK cells, T cells, and memory T cells. The result? Documented complete responses in bladder cancer patients, free of disease for over nine years. This breakthrough shatters a long-standing medical blind spot. Whether from chemo, radiation, or a severe viral infection, the body's primary defense is often wiped out. ANKTIVA represents a paradigm shift—from solely attacking disease to actively re-arming the patient's own immune system. The future of medicine is not just fighting the enemy, but empowering the army within.

Camus

55,260 görüntüleme • 9 ay önce

The Pillars of Cancer Treatment Are a Lie. Chemo and Radiation Aren't Just Brutal—They're Actively Destroying Your Natural Killer Cells, the Very Thing Standing Between You and Cancer. A stunning revelation from Dr. Patrick Soon-Shiong that reframes our entire battle against cancer. He shares a truth 460 million years in the making. Within every one of us is an ancient gift, a cell bestowed by the very process of creation: the Natural Killer (NK) cell. Dr. Soon-Shiong explains that this cell is our fundamental biological shield, the key reason humanity has survived infection, trauma, and cancer across millennia. Yet, for decades, modern medicine has waged a devastating war on this very protector. How? With the very pillars of our oncological arsenal: high-dose chemotherapy, radiation, steroid therapy, and even newer modalities. These treatments, while aimed at cancer, systematically destroy the NK cells designed to defend us. A single dose of radiation can obliterate this natural defense for a year, leaving patients vulnerable. Dr. Soon-Shiong presents a paradigm-shattering question: What if, instead of attacking the body’s innate protection, we learned to unlock and unleash it? The answer is here. After a lifetime of research, a method has been discovered and approved to activate the body as its own factory. A single intervention—a “bio-shield”—that proliferates these natural killer cells, empowering them to do what they were designed to do: protect you from cancer. The results? Real patients with bladder cancer, free of disease for a decade. This is not a future promise. This is a present reality, approved in 2024. Dr. Soon-Shiong credits the current administration for its role in moving this breakthrough forward for the entire nation. The era of destroying the body to save it is ending. The era of activating our 460-million-year-old innate defense has begun.
2:58

The Pillars of Cancer Treatment Are a Lie. Chemo and Radiation Aren't Just Brutal—They're Actively Destroying Your Natural Killer Cells, the Very Thing Standing Between You and Cancer. A stunning revelation from Dr. Patrick Soon-Shiong that reframes our entire battle against cancer. He shares a truth 460 million years in the making. Within every one of us is an ancient gift, a cell bestowed by the very process of creation: the Natural Killer (NK) cell. Dr. Soon-Shiong explains that this cell is our fundamental biological shield, the key reason humanity has survived infection, trauma, and cancer across millennia. Yet, for decades, modern medicine has waged a devastating war on this very protector. How? With the very pillars of our oncological arsenal: high-dose chemotherapy, radiation, steroid therapy, and even newer modalities. These treatments, while aimed at cancer, systematically destroy the NK cells designed to defend us. A single dose of radiation can obliterate this natural defense for a year, leaving patients vulnerable. Dr. Soon-Shiong presents a paradigm-shattering question: What if, instead of attacking the body’s innate protection, we learned to unlock and unleash it? The answer is here. After a lifetime of research, a method has been discovered and approved to activate the body as its own factory. A single intervention—a “bio-shield”—that proliferates these natural killer cells, empowering them to do what they were designed to do: protect you from cancer. The results? Real patients with bladder cancer, free of disease for a decade. This is not a future promise. This is a present reality, approved in 2024. Dr. Soon-Shiong credits the current administration for its role in moving this breakthrough forward for the entire nation. The era of destroying the body to save it is ending. The era of activating our 460-million-year-old innate defense has begun.

Camus

150,903 görüntüleme • 10 ay önce

A Cancer Breakthrough That Changes Everything In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed. This isn't a traditional chemo or radiation. It's a dual approach that empowers the body's own immune system. Here’s the revolutionary breakdown: 1. The "BioShield" Injection: The key is a stabilized form of IL-15 (Interleukin-15), a protein that acts as "food" for your Natural Killer (NK) cells. The NIH tried for a decade to develop IL-15 but failed because it naturally lasts only 2 minutes in the body. Dr. Soon-Shiong's team engineered it to last for 7 days with a simple 5-minute subcutaneous injection, continuously proliferating the patient's NK cells. 2. The Combined Infusion: Patients receive this "BioShield" injection along with an infusion of powerful NK cells, creating a targeted army to attack the cancer. The Proven Results: - Metastatic Pancreatic Cancer: Patients alive 6 years later. - Merkel Cell Carcinoma: Patients surviving 9 years. - Bladder Cancer: Approved by the FDA in April 2024, with patients disease-free for 10 years. - Lung Cancer: In new trials, the therapy has tripled survival for patients who failed everything, including chemo and checkpoint inhibitors. The therapy is also being used preemptively. The NCI has designated it for a trial on patients with Lynch syndrome (1 in 280 Americans), who have an 80% higher risk of cancers, to provide a "Cancer BioShield." The data is based on experience with over 8,000 patients. The challenge now is regulatory. Despite its pan-tumor potential, the current system requires a separate 10-year, 700,000-page approval process for each cancer type. This is a paradigm shift. We don't ask what kind of anemia you have before a blood transfusion. The body needs NK cells and T-cells to fight cancer, regardless of the tumor type.
5:24

A Cancer Breakthrough That Changes Everything In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed. This isn't a traditional chemo or radiation. It's a dual approach that empowers the body's own immune system. Here’s the revolutionary breakdown: 1. The "BioShield" Injection: The key is a stabilized form of IL-15 (Interleukin-15), a protein that acts as "food" for your Natural Killer (NK) cells. The NIH tried for a decade to develop IL-15 but failed because it naturally lasts only 2 minutes in the body. Dr. Soon-Shiong's team engineered it to last for 7 days with a simple 5-minute subcutaneous injection, continuously proliferating the patient's NK cells. 2. The Combined Infusion: Patients receive this "BioShield" injection along with an infusion of powerful NK cells, creating a targeted army to attack the cancer. The Proven Results: - Metastatic Pancreatic Cancer: Patients alive 6 years later. - Merkel Cell Carcinoma: Patients surviving 9 years. - Bladder Cancer: Approved by the FDA in April 2024, with patients disease-free for 10 years. - Lung Cancer: In new trials, the therapy has tripled survival for patients who failed everything, including chemo and checkpoint inhibitors. The therapy is also being used preemptively. The NCI has designated it for a trial on patients with Lynch syndrome (1 in 280 Americans), who have an 80% higher risk of cancers, to provide a "Cancer BioShield." The data is based on experience with over 8,000 patients. The challenge now is regulatory. Despite its pan-tumor potential, the current system requires a separate 10-year, 700,000-page approval process for each cancer type. This is a paradigm shift. We don't ask what kind of anemia you have before a blood transfusion. The body needs NK cells and T-cells to fight cancer, regardless of the tumor type.

Camus

421,950 görüntüleme • 9 ay önce

Exciting results in lung cancer today. It is my belief that treating lymphopenia in patients with low NK and T cell count, is as essential as treating anemia (low red blood cells count) or neutropenia (low neutrophil count) which occurs as a consequence of chemotherapy, independent of tumor types. This will herald in the paradigm change of treating the immune system itself and allow the immune system to cure the cancer, regardless of its anatomical location. The long-term survival in patients with bladder cancer and now in lung cancer provide evidence of the potential validity of this hypothesis, with ANKTVIA as the foundation of the Bioshield platform.
5:40

Exciting results in lung cancer today. It is my belief that treating lymphopenia in patients with low NK and T cell count, is as essential as treating anemia (low red blood cells count) or neutropenia (low neutrophil count) which occurs as a consequence of chemotherapy, independent of tumor types. This will herald in the paradigm change of treating the immune system itself and allow the immune system to cure the cancer, regardless of its anatomical location. The long-term survival in patients with bladder cancer and now in lung cancer provide evidence of the potential validity of this hypothesis, with ANKTVIA as the foundation of the Bioshield platform.

Dr. Pat Soon-Shiong

43,436 görüntüleme • 11 ay önce

A revolutionary approach to defeating cancer: Dr. Patrick Soon-Shiong unveils a game-changing strategy In a riveting discussion, Dr. Patrick Soon-Shiong, a pioneering surgeon and biotech innovator, laid out a bold, chess-like strategy to outsmart cancer—an enemy he describes as diabolically clever, hiding from the body’s immune defenses with sinister precision. Forget checkers; this is a war requiring the sophistication of Go, where every move counts. Here’s how Dr. Soon-Shiong’s cutting-edge approach is rewriting the rules of cancer treatment: Step 1: Smoke Out the Enemy Cancer isn’t just a clump of cells—it’s a cunning adversary with genomic tricks that let it cloak itself from killer T-cells. Dr. Soon-Shiong’s protocol starts by exposing the cancer’s hidden receptors. Instead of blasting the tumor with high-dose chemotherapy, he uses a low metronomic dose—a tiny amount that stresses the cancer, forcing it to reveal itself. “It’s like smoking it out,” he explains. The cancer, sensing danger, exposes its surface molecules, making it a target for the immune system. Step 2: Unleash the Body’s Elite Forces With the tumor exposed, Dr. Soon-Shiong deploys the body’s natural killer (NK) cells and T-cells, supercharged by a breakthrough molecule called BioShield. This activates NK cells, stimulates killer T-cells, and—crucially—creates memory T-cells that remember the cancer’s signature. “For the first time, we’re seeing bladder cancer patients in complete remission for nine years, still alive, without losing their bladders,” he revealed. This isn’t just treatment; it’s a long-term defense system. Step 3: Orchestrate a Multi-Front Assault Cancer thrives by suppressing the immune system, but Dr. Soon-Shiong’s approach is a battlefield symphony. He educates T-cells with a tailored vaccine, activates killer macrophages, and suppresses the suppressors—all simultaneously. Radiation? Only in tiny, precise doses (SBRT) to expose, not destroy. “High-dose radiation kills your NK and T-cells,” he warns. This is precision warfare, not carpet bombing. A Future Without Suffering Unlike traditional cancer treatments that leave patients nauseous, bald, and broken, Dr. Soon-Shiong’s protocol is outpatient-based, minimizing suffering. “We’ve treated hundreds of patients this way,” he shared. Even more revolutionary? He envisions treating patients before surgery, using the tumor itself as a vaccine to train the immune system. Imagine a world where cancer is stopped in its tracks without invasive procedures. The American Red Cross of Cancer Dr. Soon-Shiong’s vision goes beyond individual patients. By extracting and cryopreserving NK and T-cells from a single pint of blood, his team can grow billions of these immune warriors, ready to be deployed for anyone. “We could become the American Red Cross of cancer,” he declared, hinting at a future where these innovations could even shape global health policy. Why This Matters Cancer isn’t just a disease; it’s a biological mastermind that demands respect and strategy. Dr. Soon-Shiong’s approach—expose, activate, educate, and suppress—offers hope to millions facing a life-threatening diagnosis. His work proves that with the right tools, we can turn the body into its own greatest weapon. The Call to Action The FDA must recognize this multi-pronged war requires battlefield awareness, not outdated single-drug approvals. Patients deserve access to these life-saving protocols now.
6:39

A revolutionary approach to defeating cancer: Dr. Patrick Soon-Shiong unveils a game-changing strategy In a riveting discussion, Dr. Patrick Soon-Shiong, a pioneering surgeon and biotech innovator, laid out a bold, chess-like strategy to outsmart cancer—an enemy he describes as diabolically clever, hiding from the body’s immune defenses with sinister precision. Forget checkers; this is a war requiring the sophistication of Go, where every move counts. Here’s how Dr. Soon-Shiong’s cutting-edge approach is rewriting the rules of cancer treatment: Step 1: Smoke Out the Enemy Cancer isn’t just a clump of cells—it’s a cunning adversary with genomic tricks that let it cloak itself from killer T-cells. Dr. Soon-Shiong’s protocol starts by exposing the cancer’s hidden receptors. Instead of blasting the tumor with high-dose chemotherapy, he uses a low metronomic dose—a tiny amount that stresses the cancer, forcing it to reveal itself. “It’s like smoking it out,” he explains. The cancer, sensing danger, exposes its surface molecules, making it a target for the immune system. Step 2: Unleash the Body’s Elite Forces With the tumor exposed, Dr. Soon-Shiong deploys the body’s natural killer (NK) cells and T-cells, supercharged by a breakthrough molecule called BioShield. This activates NK cells, stimulates killer T-cells, and—crucially—creates memory T-cells that remember the cancer’s signature. “For the first time, we’re seeing bladder cancer patients in complete remission for nine years, still alive, without losing their bladders,” he revealed. This isn’t just treatment; it’s a long-term defense system. Step 3: Orchestrate a Multi-Front Assault Cancer thrives by suppressing the immune system, but Dr. Soon-Shiong’s approach is a battlefield symphony. He educates T-cells with a tailored vaccine, activates killer macrophages, and suppresses the suppressors—all simultaneously. Radiation? Only in tiny, precise doses (SBRT) to expose, not destroy. “High-dose radiation kills your NK and T-cells,” he warns. This is precision warfare, not carpet bombing. A Future Without Suffering Unlike traditional cancer treatments that leave patients nauseous, bald, and broken, Dr. Soon-Shiong’s protocol is outpatient-based, minimizing suffering. “We’ve treated hundreds of patients this way,” he shared. Even more revolutionary? He envisions treating patients before surgery, using the tumor itself as a vaccine to train the immune system. Imagine a world where cancer is stopped in its tracks without invasive procedures. The American Red Cross of Cancer Dr. Soon-Shiong’s vision goes beyond individual patients. By extracting and cryopreserving NK and T-cells from a single pint of blood, his team can grow billions of these immune warriors, ready to be deployed for anyone. “We could become the American Red Cross of cancer,” he declared, hinting at a future where these innovations could even shape global health policy. Why This Matters Cancer isn’t just a disease; it’s a biological mastermind that demands respect and strategy. Dr. Soon-Shiong’s approach—expose, activate, educate, and suppress—offers hope to millions facing a life-threatening diagnosis. His work proves that with the right tools, we can turn the body into its own greatest weapon. The Call to Action The FDA must recognize this multi-pronged war requires battlefield awareness, not outdated single-drug approvals. Patients deserve access to these life-saving protocols now.

Camus

94,391 görüntüleme • 1 yıl önce

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?
5:12

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?

Camus

31,209 görüntüleme • 8 ay önce

Cancer - Chemotherapy wipes out the cells that "protect your body from cancer" For decades, the fundamental protocol for fighting cancer has been chemotherapy and radiation. But what if this approach inadvertently disarms the body's most powerful weapon against the very disease it seeks to destroy? Dr. Patrick Soon-Shiong explains the profound and simple truth: When a patient undergoes chemotherapy, it systematically wipes out critical components of the immune system. 1. It wipes out red blood cells, causing anemia. We have a drug for that: Epogen. 2. It wipes out neutrophils, which prevent infection. We have a drug for that: Neupogen. 3. But most critically, it decimates the lymphocytes—the NK and T cells. Here lies the devastating irony: The NK and T cells are the only cells in the human body that can recognize and kill cancer. So, within days, the standard of care eliminates the patient's primary defense system. For 35 years, we have treated the side effects of anemia and infection, all while having no therapy to restore the very cells that matter most. Dr. Soon-Shiong’s two-decade fight has been to illuminate this paradigm. We have been unintentionally protecting the patient from the consequences of our own treatments while undermining their innate ability to survive. This principle extends beyond oncology. In Long COVID, a similar pattern emerges—a viral infection that cleverly disables the T and NK cells. The lesson is clear: The future of medicine lies not in breaking the body down, but in strategically rebuilding and empowering its innate intelligence. It’s a call to move beyond managing collateral damage and to start fortifying the core of our biological defenses.
1:47

Cancer - Chemotherapy wipes out the cells that "protect your body from cancer" For decades, the fundamental protocol for fighting cancer has been chemotherapy and radiation. But what if this approach inadvertently disarms the body's most powerful weapon against the very disease it seeks to destroy? Dr. Patrick Soon-Shiong explains the profound and simple truth: When a patient undergoes chemotherapy, it systematically wipes out critical components of the immune system. 1. It wipes out red blood cells, causing anemia. We have a drug for that: Epogen. 2. It wipes out neutrophils, which prevent infection. We have a drug for that: Neupogen. 3. But most critically, it decimates the lymphocytes—the NK and T cells. Here lies the devastating irony: The NK and T cells are the only cells in the human body that can recognize and kill cancer. So, within days, the standard of care eliminates the patient's primary defense system. For 35 years, we have treated the side effects of anemia and infection, all while having no therapy to restore the very cells that matter most. Dr. Soon-Shiong’s two-decade fight has been to illuminate this paradigm. We have been unintentionally protecting the patient from the consequences of our own treatments while undermining their innate ability to survive. This principle extends beyond oncology. In Long COVID, a similar pattern emerges—a viral infection that cleverly disables the T and NK cells. The lesson is clear: The future of medicine lies not in breaking the body down, but in strategically rebuilding and empowering its innate intelligence. It’s a call to move beyond managing collateral damage and to start fortifying the core of our biological defenses.

Camus

61,712 görüntüleme • 9 ay önce

Dr. Patrick Soon-Shiong, a pioneering surgeon and scientist, reveals a shocking truth about chemotherapy, immunity, and why we’ve been fighting cancer the wrong way for decades. Here’s what’s simple—and profound: When you undergo chemotherapy, the first casualty is your red blood cells, leading to anemia (treated with Epogen). Next, it wipes out neutrophils, leaving you vulnerable to infection (treated with Neupogen). But the most devastating effect? It destroys your NK and T cells—your body’s elite cancer-fighting forces. Think about that: The very treatment meant to kill cancer also annihilates the only cells that can actually protect you from it. For 35 years, medicine has ignored this paradox. We replace red blood cells and neutrophils—but not the lymphocytes that matter most. The result? A weakened immune system, vulnerable to relapse and secondary cancers. Now, consider long COVID. The virus is cunning—it targets the same NK and T cells, crippling immunity. The parallel is undeniable: Weakening these cells leaves the body defenseless, whether from chemo or chronic infection. Dr. Soon-Shiong’s message is clear: "We’ve been treating cancer wrong." The future lies in restoring immune function, not just attacking tumors. The fight isn’t just against cancer or viruses—it’s for the immune system itself. And after 20 years of challenging the status quo, Dr. Soon-Shiong is leading that revolution. It’s time to rethink everything.
1:47

Dr. Patrick Soon-Shiong, a pioneering surgeon and scientist, reveals a shocking truth about chemotherapy, immunity, and why we’ve been fighting cancer the wrong way for decades. Here’s what’s simple—and profound: When you undergo chemotherapy, the first casualty is your red blood cells, leading to anemia (treated with Epogen). Next, it wipes out neutrophils, leaving you vulnerable to infection (treated with Neupogen). But the most devastating effect? It destroys your NK and T cells—your body’s elite cancer-fighting forces. Think about that: The very treatment meant to kill cancer also annihilates the only cells that can actually protect you from it. For 35 years, medicine has ignored this paradox. We replace red blood cells and neutrophils—but not the lymphocytes that matter most. The result? A weakened immune system, vulnerable to relapse and secondary cancers. Now, consider long COVID. The virus is cunning—it targets the same NK and T cells, crippling immunity. The parallel is undeniable: Weakening these cells leaves the body defenseless, whether from chemo or chronic infection. Dr. Soon-Shiong’s message is clear: "We’ve been treating cancer wrong." The future lies in restoring immune function, not just attacking tumors. The fight isn’t just against cancer or viruses—it’s for the immune system itself. And after 20 years of challenging the status quo, Dr. Soon-Shiong is leading that revolution. It’s time to rethink everything.

Camus

327,541 görüntüleme • 1 yıl önce

A devastating critique of modern oncology from a leading voice, Dr. Patrick Soon-Shiong. He reveals a fundamental flaw in our 40-year war on cancer: the very treatments we hail as first-line defenses—chemotherapy and radiation—systematically destroy the patient's best long-term allies: their NK cells and T-cells. We celebrate short-term "response rates" (tumor shrinkage) as victory. But this is a pyrrhic victory. By wiping out the immune system's memory and killing cells, we leave the body defenseless against metastasis, which is ultimately what kills most patients. The tragedy is compounded by the solution. Dr. Soon-Shiong states we have the knowledge to change this paradigm now. The first step for any cancer patient should be to build and protect the immune system, not decimate it. Yet, as his clinic receives over 10,000 desperate requests with only 30 available spots, he voices a profound despair. This life-saving approach remains inaccessible to the masses, locked away by a system resistant to change. The solution, he insists, is not a distant dream. It could be made available to the nation "by a stroke of a pen." The knowledge exists. The failure is one of implementation, leaving thousands to a fate we have the power to prevent.
1:51

A devastating critique of modern oncology from a leading voice, Dr. Patrick Soon-Shiong. He reveals a fundamental flaw in our 40-year war on cancer: the very treatments we hail as first-line defenses—chemotherapy and radiation—systematically destroy the patient's best long-term allies: their NK cells and T-cells. We celebrate short-term "response rates" (tumor shrinkage) as victory. But this is a pyrrhic victory. By wiping out the immune system's memory and killing cells, we leave the body defenseless against metastasis, which is ultimately what kills most patients. The tragedy is compounded by the solution. Dr. Soon-Shiong states we have the knowledge to change this paradigm now. The first step for any cancer patient should be to build and protect the immune system, not decimate it. Yet, as his clinic receives over 10,000 desperate requests with only 30 available spots, he voices a profound despair. This life-saving approach remains inaccessible to the masses, locked away by a system resistant to change. The solution, he insists, is not a distant dream. It could be made available to the nation "by a stroke of a pen." The knowledge exists. The failure is one of implementation, leaving thousands to a fate we have the power to prevent.

Camus

856,090 görüntüleme • 9 ay önce

Dr. Patrick Soon-Shiong on the Cancer-Fighting Immune Breakthrough: Awakening the 450 Million-Year-Old Natural Killer Cell After decades of pioneering work since discovering the natural killer cell in the 1990s—a remarkable immune cell created by God and preserved through 450 million years—Dr. Patrick Soon-Shiong reveals an extraordinary breakthrough. This cell, unknown to many until the 1970s, serves as the body's first line of defense, designed to destroy cancer cells, infections like COVID, sepsis, bacteria, and fungus. Dr. Soon-Shiong emphasizes that this is not an invention, but an enlightenment: activating the body’s own natural killer cells to combat disease naturally, shifting away from toxic chemotherapy and radiation. With a single jab, they have unlocked the secret to empowering this primal cellular protector. This is evolution’s own weapon against illness, a game-changer that taps into ancient biology to revolutionize modern medicine. This insight reframes how we think about health and cancer treatment by harnessing the immune system's innate power, moving beyond harsh treatments, and embracing nature’s original disease-fighter from within. The discovery is a call to awaken the body’s own god-given defense system for a future of empowered healing.
1:58

Dr. Patrick Soon-Shiong on the Cancer-Fighting Immune Breakthrough: Awakening the 450 Million-Year-Old Natural Killer Cell After decades of pioneering work since discovering the natural killer cell in the 1990s—a remarkable immune cell created by God and preserved through 450 million years—Dr. Patrick Soon-Shiong reveals an extraordinary breakthrough. This cell, unknown to many until the 1970s, serves as the body's first line of defense, designed to destroy cancer cells, infections like COVID, sepsis, bacteria, and fungus. Dr. Soon-Shiong emphasizes that this is not an invention, but an enlightenment: activating the body’s own natural killer cells to combat disease naturally, shifting away from toxic chemotherapy and radiation. With a single jab, they have unlocked the secret to empowering this primal cellular protector. This is evolution’s own weapon against illness, a game-changer that taps into ancient biology to revolutionize modern medicine. This insight reframes how we think about health and cancer treatment by harnessing the immune system's innate power, moving beyond harsh treatments, and embracing nature’s original disease-fighter from within. The discovery is a call to awaken the body’s own god-given defense system for a future of empowered healing.

Camus

33,407 görüntüleme • 8 ay önce

The Chemotherapy Paradox – A "Cure" That Preserves the Root of Cancer? You've been told chemotherapy is a cornerstone of cancer care. But what if the standard of care is fundamentally flawed, suppressing the very system designed to heal you while protecting the engine that drives the disease? In a stunning exposition, Dr. Paul Marik pulls back the curtain on oncology's biggest dilemma. Here's the shocking truth: - Chemotherapy annihilates your immune army. It wipes out your natural killer cells and T-cells—the very soldiers your body needs to fight cancer. You are immune-suppressed, allowing the tumor a clearer path to proliferate. - Chemotherapy preserves the cancer stem cell. This is the root of the tumor. While chemo kills rapidly dividing cells, it often leaves the stem cell—the queen bee—untouched. From this root, the cancer indefinitely divides, mutates, and regrows. - Some chemo drugs may even STIMULATE the stem cell. That's right. The very treatment intended to kill cancer can, in some cases, fuel its source. "So you can't cure the patient unless you get rid of the cancer stem cell," states Dr. Marik. "Interestingly, chemotherapy doesn't kill the stem cell." This explains why "remission" is not a "cure." The cancer can return 7, 8, or 10 years later because the root was never addressed. You are in remission, not cured. The conclusion? The high-dose, "burn-and-cut" approach of traditional oncology is not holistic. It weakens the host and empowers the enemy's most resilient forces. Dr. Marik confirms: The efficacy depends on the tumor type. Cancers with a low percentage of stem cells can see long-term remission. But for many, it's a ticking time bomb. This isn't an opinion; it's a biological reality. It’s time for a paradigm shift. Share this to spark a crucial conversation. The future of oncology depends on it.
2:48

The Chemotherapy Paradox – A "Cure" That Preserves the Root of Cancer? You've been told chemotherapy is a cornerstone of cancer care. But what if the standard of care is fundamentally flawed, suppressing the very system designed to heal you while protecting the engine that drives the disease? In a stunning exposition, Dr. Paul Marik pulls back the curtain on oncology's biggest dilemma. Here's the shocking truth: - Chemotherapy annihilates your immune army. It wipes out your natural killer cells and T-cells—the very soldiers your body needs to fight cancer. You are immune-suppressed, allowing the tumor a clearer path to proliferate. - Chemotherapy preserves the cancer stem cell. This is the root of the tumor. While chemo kills rapidly dividing cells, it often leaves the stem cell—the queen bee—untouched. From this root, the cancer indefinitely divides, mutates, and regrows. - Some chemo drugs may even STIMULATE the stem cell. That's right. The very treatment intended to kill cancer can, in some cases, fuel its source. "So you can't cure the patient unless you get rid of the cancer stem cell," states Dr. Marik. "Interestingly, chemotherapy doesn't kill the stem cell." This explains why "remission" is not a "cure." The cancer can return 7, 8, or 10 years later because the root was never addressed. You are in remission, not cured. The conclusion? The high-dose, "burn-and-cut" approach of traditional oncology is not holistic. It weakens the host and empowers the enemy's most resilient forces. Dr. Marik confirms: The efficacy depends on the tumor type. Cancers with a low percentage of stem cells can see long-term remission. But for many, it's a ticking time bomb. This isn't an opinion; it's a biological reality. It’s time for a paradigm shift. Share this to spark a crucial conversation. The future of oncology depends on it.

Camus

69,487 görüntüleme • 8 ay önce

Dr. Patrick Soon-Shiong challenges the core of cancer treatment: Are we fighting cancer incorrectly? In a compelling interview, he explains how lymphocytes—Natural Killer cells and T-cells—are the body’s critical defenders, essential for defeating cancer, infections, and sepsis. Yet, modern medicine has been undermining them. Lymphocytes are the body’s elite immune cells. Natural Killer cells and T-cells are uniquely equipped to destroy cancer cells and are vital for combating life-threatening infections and sepsis. Dr. Soon-Shiong describes them as the foundation for long life and survival. But there’s a problem. Conventional cancer treatments—chemotherapy, radiation, and steroids—destroy these lymphocytes, causing lymphopenia, a depletion akin to anemia but for the immune system. For decades, medicine has inadvertently targeted the very cells needed to win the war against cancer. A breakthrough molecule, IL-15, changes everything. This protein, produced naturally in the body, acts as a master switch to activate and proliferate lymphocytes, enabling them to eradicate cancer and infections. For the first time, medicine can harness this mechanism through BioShield. BioShield leverages IL-15 to empower lymphocytes, marking a revolutionary shift in treatment. Unlike chemotherapy, which Dr. Soon-Shiong likens to a nuclear bomb that devastates the body, IL-15 strengthens the immune system to fight smarter. Why have traditional treatments fallen short? Chemotherapy and radiation may shrink tumors, achieving what’s called a response, but at a steep cost. They deplete lymphocytes, weaken immunity, and allow resistant cancer cells to hide and later return as metastases. Dr. Soon-Shiong raises a provocative question: Have treatments induced incurability? The focus on response rates and progression-free survival, standard metrics for drug approval, misses the true goal: overall survival with high quality of life. Current therapies, often dosed at the maximum tolerated level, prioritize short-term wins over long-term health. Dr. Soon-Shiong critiques this approach, suggesting that medicine has been winning battles but losing wars. By destroying lymphocytes, treatments may shrink tumors temporarily but leave patients vulnerable to relapse. The regulatory system, he argues, has incentivized flawed endpoints. BioShield’s IL-15 therapy offers hope, activating the body’s natural defenses without obliterating them. This could redefine cancer care, prioritizing immune strength and long-term survival over transient tumor shrinkage. Dr. Soon-Shiong’s vision challenges 50 years of oncology dogma. Is it possible that medicine has misunderstood cancer treatment for decades? Dr. Soon-Shiong’s insights demand reflection. By protecting and activating lymphocytes, we might unlock the body’s true potential to heal.
4:13

Dr. Patrick Soon-Shiong challenges the core of cancer treatment: Are we fighting cancer incorrectly? In a compelling interview, he explains how lymphocytes—Natural Killer cells and T-cells—are the body’s critical defenders, essential for defeating cancer, infections, and sepsis. Yet, modern medicine has been undermining them. Lymphocytes are the body’s elite immune cells. Natural Killer cells and T-cells are uniquely equipped to destroy cancer cells and are vital for combating life-threatening infections and sepsis. Dr. Soon-Shiong describes them as the foundation for long life and survival. But there’s a problem. Conventional cancer treatments—chemotherapy, radiation, and steroids—destroy these lymphocytes, causing lymphopenia, a depletion akin to anemia but for the immune system. For decades, medicine has inadvertently targeted the very cells needed to win the war against cancer. A breakthrough molecule, IL-15, changes everything. This protein, produced naturally in the body, acts as a master switch to activate and proliferate lymphocytes, enabling them to eradicate cancer and infections. For the first time, medicine can harness this mechanism through BioShield. BioShield leverages IL-15 to empower lymphocytes, marking a revolutionary shift in treatment. Unlike chemotherapy, which Dr. Soon-Shiong likens to a nuclear bomb that devastates the body, IL-15 strengthens the immune system to fight smarter. Why have traditional treatments fallen short? Chemotherapy and radiation may shrink tumors, achieving what’s called a response, but at a steep cost. They deplete lymphocytes, weaken immunity, and allow resistant cancer cells to hide and later return as metastases. Dr. Soon-Shiong raises a provocative question: Have treatments induced incurability? The focus on response rates and progression-free survival, standard metrics for drug approval, misses the true goal: overall survival with high quality of life. Current therapies, often dosed at the maximum tolerated level, prioritize short-term wins over long-term health. Dr. Soon-Shiong critiques this approach, suggesting that medicine has been winning battles but losing wars. By destroying lymphocytes, treatments may shrink tumors temporarily but leave patients vulnerable to relapse. The regulatory system, he argues, has incentivized flawed endpoints. BioShield’s IL-15 therapy offers hope, activating the body’s natural defenses without obliterating them. This could redefine cancer care, prioritizing immune strength and long-term survival over transient tumor shrinkage. Dr. Soon-Shiong’s vision challenges 50 years of oncology dogma. Is it possible that medicine has misunderstood cancer treatment for decades? Dr. Soon-Shiong’s insights demand reflection. By protecting and activating lymphocytes, we might unlock the body’s true potential to heal.

Camus

45,915 görüntüleme • 1 yıl önce

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.
2:53

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.

Camus

38,936 görüntüleme • 10 ay önce

Chemotherapy's Fatal Flaw: We're Destroying the Very System That Can Save Us. This isn't just an opinion. It's a devastating paradox at the heart of modern cancer care. As articulated by Dr. Patrick Soon-Shiong, we are systematically poisoning the body's single most powerful weapon against cancer: the immune system. Think about it. We use our most toxic chemicals to kill cancer cells, but in the process, we annihilate the patient's Natural Killer (NK) cells and T-cells—the very forces designed to fight the disease. We are winning the battle but losing the war. We even give support drugs like Epogen and Neupogen not to treat the cancer, but to allow the patient to survive more of the toxic treatment that is crippling their natural defenses. It's a vicious cycle. This "madness" has historical parallels to brutal, abandoned procedures like the radical mastectomy. How long until we view today's standard chemo protocols with the same horror? The future isn't in stronger poisons. It's in smarter immunity. The global race is on to activate the body's innate defense system, not destroy it. The question isn't if the paradigm will shift. It's when. And for countless patients, time is the enemy we are not currently beating. Agree? Disagree? The conversation starts now.
3:34

Chemotherapy's Fatal Flaw: We're Destroying the Very System That Can Save Us. This isn't just an opinion. It's a devastating paradox at the heart of modern cancer care. As articulated by Dr. Patrick Soon-Shiong, we are systematically poisoning the body's single most powerful weapon against cancer: the immune system. Think about it. We use our most toxic chemicals to kill cancer cells, but in the process, we annihilate the patient's Natural Killer (NK) cells and T-cells—the very forces designed to fight the disease. We are winning the battle but losing the war. We even give support drugs like Epogen and Neupogen not to treat the cancer, but to allow the patient to survive more of the toxic treatment that is crippling their natural defenses. It's a vicious cycle. This "madness" has historical parallels to brutal, abandoned procedures like the radical mastectomy. How long until we view today's standard chemo protocols with the same horror? The future isn't in stronger poisons. It's in smarter immunity. The global race is on to activate the body's innate defense system, not destroy it. The question isn't if the paradigm will shift. It's when. And for countless patients, time is the enemy we are not currently beating. Agree? Disagree? The conversation starts now.

Camus

31,532 görüntüleme • 11 ay önce

A Cancer Revolution Hidden in Plain Sight For 30 years, Dr. Patrick Soon-Shiong has pursued a radical truth—one that could rewrite how we treat cancer. And it’s been inside us all along. The Secret Weapon? Natural Killer (NK) Cells. These microscopic warriors evolved 450 million years ago to protect mammals. Watch this real footage—not animation—of an NK cell devouring a cancer cell. Then, the T-cell joins the fight. Together, they’re our body’s elite defense. The Paradigm Shift: What if cancer isn’t the root disease—but a symptom? A sign of immune collapse as we age or face infections? For decades, medicine has attacked cancer with tools that weaken immunity (chemotherapy, radiation, steroids). But what if we rebuild the immune system instead? The Proof: An FDA-approved therapy (already used for bladder cancer) proliferates NK cells, safely tested in 8,000 doses. This isn’t sci-fi—it’s science. The Mission: Educate the world. Challenge doctors, regulators, and patients to rethink cancer treatment. Because the cure may not come from a lab—but from harnessing what’s already within us. The Future of Medicine Starts Now.
2:44

A Cancer Revolution Hidden in Plain Sight For 30 years, Dr. Patrick Soon-Shiong has pursued a radical truth—one that could rewrite how we treat cancer. And it’s been inside us all along. The Secret Weapon? Natural Killer (NK) Cells. These microscopic warriors evolved 450 million years ago to protect mammals. Watch this real footage—not animation—of an NK cell devouring a cancer cell. Then, the T-cell joins the fight. Together, they’re our body’s elite defense. The Paradigm Shift: What if cancer isn’t the root disease—but a symptom? A sign of immune collapse as we age or face infections? For decades, medicine has attacked cancer with tools that weaken immunity (chemotherapy, radiation, steroids). But what if we rebuild the immune system instead? The Proof: An FDA-approved therapy (already used for bladder cancer) proliferates NK cells, safely tested in 8,000 doses. This isn’t sci-fi—it’s science. The Mission: Educate the world. Challenge doctors, regulators, and patients to rethink cancer treatment. Because the cure may not come from a lab—but from harnessing what’s already within us. The Future of Medicine Starts Now.

Camus

49,252 görüntüleme • 1 yıl önce

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”
8:29

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

Black Panther Capital

40,249 görüntüleme • 6 ay önce

A Medical Paradigm Built on Warfare is Failing Cancer Patients. Here’s the Breakthrough They Are Blocking. Dr. Patrick Soon-Shiong reveals a hard truth: our cancer treatment roots are in mustard gas & nuclear weapons—a system of "short-term survival scarred by fear, power, and control." He believed groundbreaking science would be embraced. He was wrong. The discovery? Your body has the ultimate weapon: the Natural Killer (NK) cell. We can now activate it with a simple protein (IL-15), creating a universal key to attack ALL cancer types. The FDA’s fatal flaw? Bureaucratic inertia & regulatory capture. They approve drugs for anemia (Epogen) or low neutrophils (Neupogen) regardless of tumor type. It's logical: you don't ask why you need a blood transfusion. Yet, when patients have low NK & T cells (lymphopenia)—a $20 test reveals this—the FDA refuses to approve IL-15 as the universal solution. It's like denying a transfusion for catastrophic blood loss. The proof is there: - ✅ Bladder cancer patients alive & cancer-free for 10+ years. - ✅ Data for pancreatic, lung, & head/neck cancers. The response? "Refused to file." They demand a randomized trial for every single cancer type—a process requiring "three lifetimes" while patients die. This isn't just about cancer. The immune system is the key to longevity. The world's oldest person, 117, had hyper-active NK cells. We have a simple, subcutaneous shot that can save lives now. The system, prioritizing money & consensus over people, is standing in the way. It's time for a revolution in medicine. The power to heal is already within us.
5:53

A Medical Paradigm Built on Warfare is Failing Cancer Patients. Here’s the Breakthrough They Are Blocking. Dr. Patrick Soon-Shiong reveals a hard truth: our cancer treatment roots are in mustard gas & nuclear weapons—a system of "short-term survival scarred by fear, power, and control." He believed groundbreaking science would be embraced. He was wrong. The discovery? Your body has the ultimate weapon: the Natural Killer (NK) cell. We can now activate it with a simple protein (IL-15), creating a universal key to attack ALL cancer types. The FDA’s fatal flaw? Bureaucratic inertia & regulatory capture. They approve drugs for anemia (Epogen) or low neutrophils (Neupogen) regardless of tumor type. It's logical: you don't ask why you need a blood transfusion. Yet, when patients have low NK & T cells (lymphopenia)—a $20 test reveals this—the FDA refuses to approve IL-15 as the universal solution. It's like denying a transfusion for catastrophic blood loss. The proof is there: - ✅ Bladder cancer patients alive & cancer-free for 10+ years. - ✅ Data for pancreatic, lung, & head/neck cancers. The response? "Refused to file." They demand a randomized trial for every single cancer type—a process requiring "three lifetimes" while patients die. This isn't just about cancer. The immune system is the key to longevity. The world's oldest person, 117, had hyper-active NK cells. We have a simple, subcutaneous shot that can save lives now. The system, prioritizing money & consensus over people, is standing in the way. It's time for a revolution in medicine. The power to heal is already within us.

Camus

71,957 görüntüleme • 10 ay önce

Dr. Patrick Soon-Shiong: "The Disease of Cancer is a Symptom. The Root Cause is a Collapse of the Immune System." A startling discovery is changing everything we know about cancer and longevity. The key isn't found in a new drug, but in a simple, often-ignored number on your blood test: the Absolute Lymphocyte Count (ALC). As Dr. Soon-Shiong explains, if your ALC drops below 1000 cells/μL (a condition known as lymphopenia), the statistical risk of a shortened lifespan increases dramatically. This isn't a new theory; it's a clinical fact supported by hundreds of publications spanning decades. The data is undeniable: whether for breast, lung, pancreatic, or any other cancer, lymphopenia consistently predicts a significantly worse outcome. The reason is profound in its simplicity. Your ALC is your immune army. These lymphocytes and T-cells are your body's only dedicated soldiers to fight infection, prevent cancer, and stop metastasis. A low count means the front line is defenseless. We have been treating the symptom—the tumor—while ignoring the root cause. The disease is not the cancer; the cancer is a symptom of a failed immune system. This is a fundamental paradigm shift. The future of medicine lies in treating the host, not just the disease. By restoring immune competence, we don't just attack one illness; we empower the body to defend itself against many. It is a simple, yet profound, unlocking of a new era in healthcare.
1:56

Dr. Patrick Soon-Shiong: "The Disease of Cancer is a Symptom. The Root Cause is a Collapse of the Immune System." A startling discovery is changing everything we know about cancer and longevity. The key isn't found in a new drug, but in a simple, often-ignored number on your blood test: the Absolute Lymphocyte Count (ALC). As Dr. Soon-Shiong explains, if your ALC drops below 1000 cells/μL (a condition known as lymphopenia), the statistical risk of a shortened lifespan increases dramatically. This isn't a new theory; it's a clinical fact supported by hundreds of publications spanning decades. The data is undeniable: whether for breast, lung, pancreatic, or any other cancer, lymphopenia consistently predicts a significantly worse outcome. The reason is profound in its simplicity. Your ALC is your immune army. These lymphocytes and T-cells are your body's only dedicated soldiers to fight infection, prevent cancer, and stop metastasis. A low count means the front line is defenseless. We have been treating the symptom—the tumor—while ignoring the root cause. The disease is not the cancer; the cancer is a symptom of a failed immune system. This is a fundamental paradigm shift. The future of medicine lies in treating the host, not just the disease. By restoring immune competence, we don't just attack one illness; we empower the body to defend itself against many. It is a simple, yet profound, unlocking of a new era in healthcare.

Camus

281,295 görüntüleme • 11 ay önce

10 Headlines They Don’t Want You to Hear Today #10 – Entrepreneur and health innovator Dr. Patrick Soon-Shiong concludes that the disease of cancer is merely a symptom of a collapsed immune system. According to Soon-Shiong, the key marker that’s been overlooked for decades is your Absolute Lymphocyte Count (ALC). He says when it drops below 1000 cells per microliter — a condition called lymphopenia — your body is left defenseless against infection, cancer growth, and metastasis. And science dating back to the 1990s reveals people with lymphopenia have much worse cancer outcomes. “What ALC is, actually, is your lymphocytes and your T-cells,” he told Megyn Kelly. “And the lymphocytes and T-cells are the only cells that really matter to prevent infection, to prevent cancer, to treat the cancer, to prevent metastasis,” he explained. “[So] it’s simple and yet profound that we’ve unlocked a paradigm change where we treat the host, i.e., the immune system, rather than the disease. In fact… the root cause of cancer is the collapse of the immune system.” Hat Tip: Camus SEE THE NEXT 9 STORIES BELOW
1:56

10 Headlines They Don’t Want You to Hear Today #10 – Entrepreneur and health innovator Dr. Patrick Soon-Shiong concludes that the disease of cancer is merely a symptom of a collapsed immune system. According to Soon-Shiong, the key marker that’s been overlooked for decades is your Absolute Lymphocyte Count (ALC). He says when it drops below 1000 cells per microliter — a condition called lymphopenia — your body is left defenseless against infection, cancer growth, and metastasis. And science dating back to the 1990s reveals people with lymphopenia have much worse cancer outcomes. “What ALC is, actually, is your lymphocytes and your T-cells,” he told Megyn Kelly. “And the lymphocytes and T-cells are the only cells that really matter to prevent infection, to prevent cancer, to treat the cancer, to prevent metastasis,” he explained. “[So] it’s simple and yet profound that we’ve unlocked a paradigm change where we treat the host, i.e., the immune system, rather than the disease. In fact… the root cause of cancer is the collapse of the immune system.” Hat Tip: Camus SEE THE NEXT 9 STORIES BELOW

The Vigilant Fox 🦊

1,119,955 görüntüleme • 11 ay önce